Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

AVDL holding history

Avadel Pharmaceuticals PLC in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVDL overviewAll 13F holders of AVDLFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of AVDL by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−20,154−100.0%Sold outHolders
Q4 202520,154$434.3K<0.1%−3,285−14.0%ReducedHolders
Q3 202523,439$357.9K<0.1%+4,063+21.0%AddedHolders
Q2 202519,376$171.5K<0.1%+1,759+10.0%AddedHolders
Q1 202517,617$137.9K<0.1%+17,467+11,644.7%AddedHolders
Q4 2024150$1.58K<0.1%−12,231−98.8%ReducedHolders
Q3 202412,381$162.4K<0.1%+938+8.2%AddedHolders
Q2 202411,443$160.9K<0.1%00.0%UnchangedHolders
Q1 202411,443$193.3K<0.1%−6,359−35.7%ReducedHolders
Q4 202317,802$251.4K<0.1%−1,676−8.6%ReducedHolders
Q3 202319,478$200.6K<0.1%+438+2.3%AddedHolders
Q2 202319,040$313.8K<0.1%+584+3.2%AddedHolders
Q1 202318,456$169.1K<0.1%+849+4.8%AddedHolders
Q4 202217,607$126.1K<0.1%+543+3.2%AddedHolders
Q3 202217,064$85.0K<0.1%+1,277+8.1%AddedHolders
Q2 202215,787$39.0K<0.1%+2,083+15.2%AddedHolders
Q1 202213,704$94.0K<0.1%+2,353+20.7%AddedHolders
Q4 202111,351$92.0K<0.1%+11,351NewHolders
Q2 20210$00.0%−15,700−100.0%Sold outHolders
Q1 202115,700$142.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.